AU6705594A - Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation - Google Patents

Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation

Info

Publication number
AU6705594A
AU6705594A AU67055/94A AU6705594A AU6705594A AU 6705594 A AU6705594 A AU 6705594A AU 67055/94 A AU67055/94 A AU 67055/94A AU 6705594 A AU6705594 A AU 6705594A AU 6705594 A AU6705594 A AU 6705594A
Authority
AU
Australia
Prior art keywords
compositions
preparation
containing recombinant
antigen containing
recombinant salmonella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67055/94A
Inventor
Roy Curtiss Iii
Florian Schodel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU6705594A publication Critical patent/AU6705594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU67055/94A 1993-04-15 1994-04-15 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation Abandoned AU6705594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4816693A 1993-04-15 1993-04-15
US048166 1993-04-15
PCT/US1994/004168 WO1994024291A2 (en) 1993-04-15 1994-04-15 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation

Publications (1)

Publication Number Publication Date
AU6705594A true AU6705594A (en) 1994-11-08

Family

ID=21953082

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67055/94A Abandoned AU6705594A (en) 1993-04-15 1994-04-15 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation

Country Status (2)

Country Link
AU (1) AU6705594A (en)
WO (1) WO1994024291A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274792B1 (en) 1995-06-20 2001-08-14 Ming-Tang Chang Plants and processes for obtaining them
US5922583A (en) * 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
US6024961A (en) 1997-11-14 2000-02-15 Washington University Recombinant avirulent immunogenic S typhi having rpos positive phenotype
EP2150616A4 (en) 2007-05-10 2011-07-27 Univ Arizona Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
US9040059B2 (en) 2007-10-05 2015-05-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting a protective immune response against C. perfringens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
WO2010135563A1 (en) 2009-05-22 2010-11-25 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
EP2526185A4 (en) 2010-01-22 2013-07-24 Univ Arizona BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2167304T3 (en) * 1987-06-22 2002-05-16 Medeva Holdings Bv PEPTIDE CONTAINING THE SURFACE ANTIGEN OF HEPATITIS B.
US5112749A (en) * 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein

Also Published As

Publication number Publication date
WO1994024291A3 (en) 1994-12-08
WO1994024291A2 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
GB2228857B (en) Oxygen-absorbing package,composition and method of formulation thereof
AU649973B2 (en) Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
AU2170592A (en) Protein compositions having reduced-hygroscopic properties and methods for preparing same
AU6017194A (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
AU2578892A (en) Mouthrinse and method of preparation
AU2971395A (en) Ceramic products, methods for their preparation, and glazing formulations for such products
AU678971B2 (en) Compositions and methods for vaccination against coronaviruses
IL110160A0 (en) Phosphopeptides, their preparation and pharmaceutical compositions containing them
AU6705594A (en) Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation
AU698886B2 (en) Flavor enhancing composition containing colloidal silica and method for its preparation and use
HUP9800260A3 (en) Method for preparing recombinant adenovirus, procaryotic plasmids useful for same, and pharmaceutical preparations containing same
EP0693931A4 (en) Immunogenic cancer proteins and peptides and method of use
HU9303298D0 (en) N,n-disubstituel (aryl-cikloalkyl)-amins and their salts, pharmaceutical components, containing them, their use and method of preparation
AU1283588A (en) New pharmaceutical compositions in the form of beadlets and method
AU4878390A (en) Transparent antiperspirant compositions and method of preparation
AU5212093A (en) Dihydro - and tetrahydro-isoquinolines, process for their preparation and pharmaceutical compositions containing same
AU6285194A (en) Stabilised pharmaceutical compositions and methods for preparing same
HUT65448A (en) New immunogenic polypeptides, vaccines containing them and method for preparation and use of them
AP9600784A0 (en) Oxathiolanes method for their preparation and pharmaceutical compositions containing them
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU6524386A (en) Method for administering vaccines and compositions therefor
AU7008494A (en) Methods and compositions for (salmonella)-based vaccines
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
AU7044194A (en) Preparation of microparticles and method of immunization